Lactobacillus Rhamnosus GG

You take a probiotic every day. This test answers a narrow but useful question: is the strain on the label showing up in your stool while you take it? It looks for DNA from one specific bacterial strain, Lactobacillus rhamnosus GG, also sold as LGG and listed on some labels as ATCC 53103, in a stool sample.

What it does not tell you is whether your gut is healthy. This strain is not a native resident of the human gut that you can be deficient in. If you have never taken it, a result near zero is the expected finding, not a problem to fix.

What the Test Actually Detects

The assay uses PCR, a lab technique that copies a target stretch of DNA until it can be counted. It looks for genetic sequences unique to this strain, and it finds them whether the bacteria are alive, dying, or already dead. That matters more than it sounds.

In a small pilot trial in hospitalized adults taking this strain while on broad-spectrum antibiotics, stool PCR found its DNA in every recipient tested that way, while growing live colonies from stool succeeded in only a minority of the people who received it. Live recovery was unreliable, but the DNA still came through.

So a positive PCR result confirms that strain DNA went in and came out. It does not confirm that living organisms are doing anything useful inside you. In probiotic recovery studies, quantitative PCR routinely reports counts well above culture on the same sample, often around tenfold or more, for exactly this reason: it counts DNA, not survivors.

Passing Through, Not Moving In

The first thing to understand before ordering this test is that this strain does not colonize the adult gut permanently. It is a visitor.

In healthy adults taking about 10 billion CFU a day, the strain goes from undetectable or barely detectable in stool to easy to measure, a jump of several orders of magnitude over placebo. Stop taking it and levels fall back to baseline within one to two weeks. A colonic biopsy study found the strain can cling to the lining of the colon a while longer, still recoverable from tissue about a week after oral intake stops, but that is a tail, not a foothold.

This reframes what a result means. A high number says DNA from the product reached stool after recent use. A low or absent number says you stopped, or never started, or the product did not deliver the strain you thought it did. None of those readings is a statement about your underlying gut health.

Why Low Is Normal

Lactobacillus species as a group are usually a tiny part of the adult stool community. Older culture and microscope studies put typical fecal lactobacilli around 0.01% of total bacteria, and many adults have none detected. During daily supplementation, this strain can become easy to find, but it still behaves like a small transient passenger rather than a resident.

A DNA-survey analysis of more than 6,000 people found that gut Lactobacillus patterns vary widely by geography, age, and health status, and that higher levels are not reliably better. In that dataset, elevated native Lactobacillus tracked alongside conditions including cirrhosis, type 2 diabetes, and inflammatory bowel disease. Associations varied by species and study group.

That sounds backwards if you think of these bacteria as unambiguously good. Here is the resolution: this is not a more-is-better marker. Native Lactobacillus levels are a passive readout of the ecosystem around them, and in a disrupted gut they can bloom for reasons that have nothing to do with health. The supplemented strain you are measuring is a separate story entirely, one about intake and transit. Do not read your number as a score.

What the Strain Itself Does, and Does Not Do

The test is about transit. You are probably taking the supplement for a reason, so the clinical record matters. It is mixed.

In children with acute infectious diarrhea, meta-analyses find the strain shortens illness by roughly a day at daily doses of 10 billion CFU or more. A separate meta-analysis found it lowers the risk of antibiotic-associated diarrhea in children, roughly halving the risk. A 2025 systematic review of randomized trials reached the same conclusion with moderate-certainty evidence for diarrhea outcomes in children.

Then there is the trial that complicates all of it. A multicenter randomized trial in 971 preschool children with acute gastroenteritis found a five-day course did nothing: median diarrhea duration was 49.7 hours with the probiotic versus 50.9 hours with placebo. No difference in severity, vomiting, or anything else measured.

The strain also fails at some things it is widely marketed for. In hospitalized adults, it did not clear vancomycin-resistant enterococci from the gut in two separate randomized trials. It did not preserve insulin-producing cell function in children with new-onset type 1 diabetes. In healthy adults, high daily doses left the broad mix of gut bacteria and the fecal protein profile mostly unchanged.

One Sample Tells You Less Than You Think

Gut bacterial counts swing hard from day to day. In daily stool DNA profiling of adults, within-person absolute abundance fluctuated up to a hundredfold over six weeks, and for many bacterial groups the day-to-day swing inside one person rivaled the differences between different people. Technical noise from the sequencing itself was several times smaller than this biological swing, so the variability is real, not a lab artifact.

Stool moisture and how fast things move through your gut are the main drivers. A loose sample and a firm one from the same person on consecutive days can produce meaningfully different numbers.

Sampling frequency matters enough to change conclusions. In one infant followed nearly daily through the first year of life, a number of bacterial groups shifted around probiotic use in the full dataset. When the data were thinned to weekly samples, those shifts were no longer detected consistently.

A one-off result several weeks after your last dose tells you almost nothing. If you compare results, match the product, dose schedule, stool consistency, collection timing, and time since last dose.

When the Result Will Mislead You

• Timing since your last dose: shedding drops sharply within one to two weeks of stopping. Test a month after finishing a bottle and you will get a near-zero result that says nothing about whether the product worked.
• Antibiotics on board: PCR will still find the DNA of organisms the antibiotic has already killed. A strong positive during antibiotic therapy does not mean live bacteria are present and working.
• Strain versus species confusion: this assay is strain-specific. A different Lactobacillus rhamnosus product, or a related species like L. paracasei, may not register, and generic Lactobacillus counts on a broad panel are not the same measurement.
• Stool consistency on the day: transit time and water content shift absolute bacterial counts substantially, which is why a single sample is a weak estimate.

What to Do With an Unexpected Result

If you have been taking a daily product and the strain is undetectable, the most likely explanations are, in order: you sampled too long after your last dose, the product lacks the strain or is underdosed, or it contains a different strain than you assumed. Check the label for the strain designation, confirm storage and expiry, repeat the sample while dosing consistently, and consider switching products if a matched-conditions repeat is still negative.

If the strain is clearly present but your symptoms have not moved, that is useful information too, and it points away from delivery as the problem. Transit is confirmed; the strain simply is not doing what you hoped for your particular complaint. Persistent bloating, pain, or altered stools with confirmed probiotic transit is a reason to look at other markers rather than to escalate the dose. Fecal calprotectin, which tracks inflammation in the gut lining, and pancreatic elastase, which tracks digestive enzyme output, address different questions entirely. Pair this test with a broader stool panel or a full microbiome profile rather than repeating it alone.

One situation warrants a clinician rather than another test. Lactobacillus bloodstream infection is rare but documented, mostly in people with severe underlying illness, immune suppression, central lines, or major recent surgery. If you are immunocompromised, have a central line, or have recently had major abdominal surgery, discuss probiotic use with your physician before starting, regardless of what a stool test shows.